Neumora Therapeutics NMRA
NASDAQ NMRA
$0.68 -0.01 (-2.05%)
At close: Sep 29, 2026 · 4:00 PM EDT

Neumora Therapeutics (NMRA) Interest Expenses (2025 - 2026)

Updated

Neumora Therapeutics' Interest Expenses was $1.82 million in Q2 2026, up 317.4% from $436,000 a year earlier but down 1.8% from the prior quarter.

Analysis

Neumora Therapeutics (NMRA) Interest Expenses (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Neumora Therapeutics' Interest Expenses was $6.46 million through Jun 30, 2026; for FY2025, it came in at $3.22 million.

  • Quarterly Interest Expenses has moved between $436,000 (Q2 2025) and $2.04 million (Q4 2025) over five years.
  • Per Business Quant data, NMRA's Interest Expenses in the three quarters before Q2 2026 was $1.85 million (Q1 2026), $2.04 million (Q4 2025) and $747,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 281.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -435.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 247.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Neumora Therapeutics 129.65 Mn 129.65 Mn - 1.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.82 Mn
Mar 31, 2026 1.85 Mn
Dec 31, 2025 2.04 Mn
Sep 30, 2025 747,000.00
Jun 30, 2025 436,000.00
API Access

Neumora Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=NMRA&period=max&api_key=YOUR_API_KEY